Abstract
Substance-related and addictive disorders are maladaptive patterns of substance use or behavior characterized by loss of control, compulsivity, and harmful consequences. While these disorders have common core symptoms, there are wide-ranging features influenced by the environment, addictive behavior, and intrinsic characteristics of the person at hand. According to the World Health Organization (WHO), on an annual global basis, approximately 275 million people use intoxicating substances (5.6% of the population), 31 million people have a substance-use disorder, and 450,000 die as a result of their substance use. Research over the last several decades has demonstrated that substance-related disorders result from a complex interplay of neurobiology, psychology, and social factors. This chapter reviews the epidemiology, etiology, pathophysiology, phenomenology, and treatment of substance-related and addictive disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association (APA). Substance-related and addictive disorders. Diagnostic and statistical manual of mental disorders. 5th ed. DSM library. Arlington, VA: American Psychiatric Association; 2013.
National Institute on Drug Abuse (NIDA). The National Institute on Drug Abuse Media Guide: how to find what you need to know about drug use and addiction. Washington DC: National Institute on Drug Abuse. Contract No.: October 1; 2020.
United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020. Vienna, Austria: United Nations. Contract No.: Sales No. E.20.XI.6; 2020.
World Health Organization (WHO). Global Status Report on Alcohol and Health 2018. Geneva: World Health Organization. Contract No.: License: CC BY-NC-SA 3.0 IGO; 2018.
Substance Abuse and Mental Health Services Administration (SAMHSA). Key Substance Use and Mental Health Indicators in the United States: results from the 2019 National Survey on Drug Use and Health. Rockvile, MD: Substance Abuse and Mental Health Services Administration. Contract No. PEP20-07-01-001; 2020.
Potenza MN, Balodis IM, Derevensky J, Grant JE, Petry NM, Verdejo-Garcia A, et al. Gambling disorder. Nat Rev Dis Primers. 2019;5(1):51. https://doi.org/10.1038/s41572-019-0099-7.
Nautiyal KM, Okuda M, Hen R, Blanco C. Gambling disorder: an integrative review of animal and human studies. Ann N Y Acad Sci. 2017;1394(1):106–27. https://doi.org/10.1111/nyas.13356.
WHO. Addictive behaviors. In: Health topics. World Health Organization; 2020. https://www.who.int/health-topics/addictive-behaviours#tab=tab_1. Accessed Dec 2020.
Agrawal A, Lynskey MT. Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction. 2008;103(7):1069–81. https://doi.org/10.1111/j.1360-0443.2008.02213.x.
Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD, et al. Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clin Pharmacol Ther. 2010;88(6):779–91. https://doi.org/10.1038/clpt.2010.175.
Agrawal A, Verweij KJH, Gillespie NA, Heath AC, Lessov-Schlaggar CN, Martin NG, et al. The genetics of addiction—a translational perspective. Transl Psychiatry. 2012;2(7):e140. https://doi.org/10.1038/tp.2012.54.
U.S. Department of Health and Human Services (HHS) Office of the Surgeon General. Facing Addiction in America: the surgeon general’s report on alcohol, drugs, and health. Washington, DC; 2016.
Strathearn L, Mertens CE, Mayes L, Rutherford H, Rajhans P, Xu G, et al. Pathways relating the neurobiology of attachment to drug addiction. Front Psych. 2019;10:737. https://doi.org/10.3389/fpsyt.2019.00737.
Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–73.
Bowen MT, Neumann ID. Rebalancing the addicted brain: oxytocin interference with the neural substrates of addiction. Trends Neurosci. 2017;40(12):691–708. https://doi.org/10.1016/j.tins.2017.10.003.
Liu M, Jiang Y, Wedow R, Li Y, Brazel DM, Chen F, et al. Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet. 2019;51(2):237–44. https://doi.org/10.1038/s41588-018-0307-5.
Belcher AM, Volkow ND, Moeller FG, Ferré S. Personality traits and vulnerability or resilience to substance use disorders. Trends Cogn Sci. 2014;18(4):211–7. https://doi.org/10.1016/j.tics.2014.01.010.
Sarlin E. Substance use disorders are associated with major medical illnesses and mortality risk in a large integrated health care system. In: NIDA Notes. National Institute of Drug Abuse; 2017. https://www.drugabuse.gov/news-events/nida-notes/2017/10/substance-use-disorders-are-associated-major-medical-illnesses-mortality-risk-in-large-integrated#figure2. Accessed May 2020.
NIDA. Common Comorbidities with Substance Use Disorders Research Report. National Institute on Drug Abuse; 2020. https://www.drugabuse.gov/publications/research-reports/common-comorbidities-substance-use-disorders/part-1-connection-between-substance-use-disorders-mental-illness.
Spooner C, Hetherington K. Social determinants of drug use. Sydney, Australia: National Drug and Alcohol Research Centre; 2005. Contract No.: 228.
Shokoohi M, Bauer GR, Kaida A, Logie CH, Lacombe-Duncan A, Milloy MJ, et al. Patterns of social determinants of health associated with drug use among women living with HIV in Canada: a latent class analysis. Addiction. 2019;114(7):1214–24. https://doi.org/10.1111/add.14566.
Valdez LA, Garcia DO, Ruiz J, Oren E, Carvajal S. Exploring structural, sociocultural, and individual barriers to alcohol abuse treatment among hispanic men. Am J Mens Health. 2018;12(6):1948–57. https://doi.org/10.1177/1557988318790882.
Welte JW, Barnes GM, Tidwell M-CO, Wieczorek WF. Predictors of problem gambling in the U.S. J Gambl Stud. 2017;33(2):327–42. https://doi.org/10.1007/s10899-016-9639-1.
NIDA. Drugs, brains, and behavior: the science of addiction. Washington DC: National Institute on Drug Abuse; 2020.
Tabakoff B, Hoffman PL. The neurobiology of alcohol consumption and alcoholism: an integrative history. Pharmacol Biochem Behav. 2013;113:20–37. https://doi.org/10.1016/j.pbb.2013.10.009.
Ries RK, Fiellin DA, Miller SC. The ASAM principles of addiction medicine. 5th ed. Philadelphia: Wolters Kluwer Health; 2015.
New Zealand Drug Foundation. Managing withdrawal. https://www.drugfoundation.org.nz/info/helping-someone/managing-withdrawal.
Volkow ND, Chang L, Wang G-J, Fowler JS, Franceschi D, Sedler M, et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci. 2001;21(23):9414. https://doi.org/10.1523/JNEUROSCI.21-23-09414.2001.
NIDA. Principles of drug addiction treatment: a research-based guide. 3rd edn. Contract No.: NIH Publication No. 12–4180; 2018.
APA. Conditions for Further Study. Diagnostic and statistical manual of mental disorders. 5th ed. DSM library. Arlington, VA: American Psychiatric Association; 2013. p. 783–808.
Kafka MP. Hypersexual disorder: a proposed diagnosis for DSM-V. Arch Sex Behav. 2010;39(2):377–400. https://doi.org/10.1007/s10508-009-9574-7.
Clark L, Lawrence AJ, Astley-Jones F, Gray N. Gambling near-misses enhance motivation to gamble and recruit win-related brain circuitry. Neuron. 2009;61(3):481–90. https://doi.org/10.1016/j.neuron.2008.12.031.
Ambre J, Fischman M, Ruo TI. Urinary excretion of ecgonine methyl ester, a major metabolite of cocaine in humans. J Anal Toxicol. 1984;8(1):23–5.
Volkow ND, Fowler JS, Wang GJ, Swanson JM. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry. 2004;9(6):557–69. https://doi.org/10.1038/sj.mp.4001507.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zein, M., Danovitch, I. (2023). Substance-Related and Addictive Disorders. In: IsHak, W.W. (eds) Atlas of Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-031-15401-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-031-15401-0_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15400-3
Online ISBN: 978-3-031-15401-0
eBook Packages: MedicineMedicine (R0)